I’ve said it before and I’ll say it again. Look for FDA green light by Q4, IMO. The last hurdle, the lynchpin of this entire therapy in Phase 3 comes down to one word: efficacy.
In the PR, notice how Jenny mentioned it. Twice.
FOCUS trial is an FDA SPA, is it not? Does anyone really believe the FOCUS trial threshold requirement was the only thing DCTH and Jenny talked about? Uh huh.
Politics aside, anyone watch the State of the Union. Interesting comment he mentioned about fast tracking certain types of drugs...
Mais, Oui!
BOOM.
Of course, just my humble opinion...
From the PR:
1. Our commercialization efforts in Europe have established a considerable body of published and presented research data that demonstrates the safety and efficacy of this therapy in appropriate patients
2. We continue to leverage this experience to validate the safety and efficacy of the melphalan/Hepatic Delivery System (CHEMOSAT) in our clinical trials.
I think long term DCTH better off on own, but will likely partner with ATNX or a substantially similar company in return for exclusive access to the therapy.
Picked up another 16K yesterday at $.0295. Unbelievable.
Later this year, I’m going to blush when I look back and see just how
cheap DCTH was to be had, IMO.
The fever’s going to break soon.
The stars have begun to align.
For now I’ll issue the standard “IN MY OPINION”, because that’s what it is.
Later this year, I’ll issue: “I told you so”.
BOOM.
Auf Wiedersehen!
Look for MAXM and CDEL to unload the rest today. If they don't post, they'll let it move up and get one last bite of the soon to be forbidden fruit, DCTH. Yeah, that's right, I said it. LOL.
Once these jokers are completely cleared out (very soon), that's when we're going to start seeing some fireworks.
P.S. HULK LIKE GREEEEEN!!!
P.P.S. I am going to watch Frozen today.
